Lehman David Aaron's Form 4 filing
Pulmonx Corp (LUNG) · filed Mar 4, 2026
- Accession no.
- 0001354228-26-000002
- Filed
- Mar 4, 2026
- Trade date
- Mar 2, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions. Open-market sales total $17.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lehman David AaronCIK 0001354228 | Officer (GENERAL COUNSEL) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | Common Stock | SSaleDisposed | −1,163 | $1.43 | −$1,663.09 | 251,829 | Direct | |
| Mar 2, 2026 | Common Stock | SSaleDisposed | −4,433 | $1.43 | −$6,339.19 | 247,396 | Direct | |
| Mar 2, 2026 | Common Stock | SSaleDisposed | −2,590 | $1.43 | −$3,703.7 | 244,806 | Direct | |
| Mar 2, 2026 | Common Stock | SSaleDisposed | −4,051 | $1.43 | −$5,792.93 | 240,755 | Direct | |
| Mar 2, 2026 | Common Stock | AGrant or awardAcquired | +150,000 | $0.00 | $0 | 390,755 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.